These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17630270)

  • 21. Reminder packaging for improving adherence to self-administered long-term medications.
    Mahtani KR; Heneghan CJ; Glasziou PP; Perera R
    Cochrane Database Syst Rev; 2011 Sep; (9):CD005025. PubMed ID: 21901694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes.
    Tan JP; Cheng KKF; Siah RC
    J Adv Nurs; 2019 Nov; 75(11):2478-2494. PubMed ID: 30993749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving compliance in your dyslipidemic patient: an evidence-based approach.
    Becker DM; Allen JK
    J Am Acad Nurse Pract; 2001 May; 13(5):200-7. PubMed ID: 11930470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation.
    Ara R; Pandor A; Stevens J; Rees A; Rafia R
    Health Technol Assess; 2009 Jul; 13(34):1-74, 75-118. PubMed ID: 19604457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to lipid-lowering agents.
    Ege MR; Yucel O; Acikgoz S
    Int J Clin Pract; 2011 Dec; 65(12):1321. PubMed ID: 22093541
    [No Abstract]   [Full Text] [Related]  

  • 26. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review.
    Gossec L; Tubach F; Dougados M; Ravaud P
    Am J Med Sci; 2007 Oct; 334(4):248-54. PubMed ID: 18030180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.
    O'Donnell DC; Brown CM; Piziak VK
    Am J Health Syst Pharm; 2001 Jun; 58(11):1017-21. PubMed ID: 11402475
    [No Abstract]   [Full Text] [Related]  

  • 28. Initial non-adherence to lipid-lowering medication: a systematic literature review.
    Cooke CE; Robertson T
    BMC Prim Care; 2024 Aug; 25(1):284. PubMed ID: 39103774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients.
    Kiortsis DN; Giral P; Bruckert E; Turpin G
    J Clin Pharm Ther; 2000 Dec; 25(6):445-51. PubMed ID: 11123498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor adherence with hypolipidemic drugs: a lost opportunity.
    Tsuyuki RT; Bungard TJ
    Pharmacotherapy; 2001 May; 21(5):576-82. PubMed ID: 11349746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transtheoretical model intervention for adherence to lipid-lowering drugs.
    Johnson SS; Driskell MM; Johnson JL; Dyment SJ; Prochaska JO; Prochaska JM; Bourne L
    Dis Manag; 2006 Apr; 9(2):102-14. PubMed ID: 16620196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of adherence to prescribed medication.
    Insull W
    Adv Exp Med Biol; 1985; 183():349-60. PubMed ID: 3898749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing drug compliance in lipid-lowering treatment.
    LaRosa JH; LaRosa JC
    Arch Fam Med; 2000; 9(10):1169-75. PubMed ID: 11115225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care.
    Diwan VK; Wahlström R; Tomson G; Beermann B; Sterky G; Eriksson B
    J Clin Epidemiol; 1995 May; 48(5):705-11. PubMed ID: 7730925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence Pattern of Lipid Lowering Drugs in a Tertiary Care Hospital.
    Khatun A; Saha SK; Ajmery S; Roy P; Naushad AN; Khatun S
    Mymensingh Med J; 2017 Apr; 26(2):266-271. PubMed ID: 28588160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication adherence in patients with chronic non-malignant pain: is there a problem?
    Broekmans S; Dobbels F; Milisen K; Morlion B; Vanderschueren S
    Eur J Pain; 2009 Feb; 13(2):115-23. PubMed ID: 18467138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochrane corner: interventions to improve adherence to lipid-lowering medication.
    van Driel ML; Morledge MD; Ulep R; Shaffer JP; Davies P; Deichmann R
    Heart; 2018 Mar; 104(5):367-369. PubMed ID: 29440453
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancing adherence in randomized controlled clinical trials.
    Shumaker SA; Dugan E; Bowen DJ
    Control Clin Trials; 2000 Oct; 21(5 Suppl):226S-32S. PubMed ID: 11018580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study shows poor persistence with lipid-lowering therapy, even when cost not a factor.
    Am J Health Syst Pharm; 1998 Aug; 55(15):1556, 1558. PubMed ID: 9706177
    [No Abstract]   [Full Text] [Related]  

  • 40. Carcinogenicity of lipid-lowering drugs.
    Laws A
    JAMA; 1996 May; 275(19):1480; author reply 1481-2. PubMed ID: 8622217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.